Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study
Bariatric surgery improves obesity-related comorbidities. Methylarginines are biomarkers of cardiometabolic risk, liver steatosis, and insulin resistance. Here, we aimed to investigate methylarginines in obese patients undergoing bariatric surgery and compared them to age- and sex-matched healthy su...
Guardado en:
Autores principales: | Julie Poirier, Chloé Cloteau, Audrey Aguesse, Xavier Billot, Etienne Thévenot, Michel Krempf, René Valéro, Marie Maraninchi, Mikaël Croyal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/100e0038ff6c4e0eb66208eee4768b3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metabolic and Bariatric Surgery Chapter of the Association
of Polish Surgeons.
Bariatric and metabolic surgery care standards
por: Jacek Szeliga, et al.
Publicado: (2020) -
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
por: Cadegiani FA, et al.
Publicado: (2016) -
Nutritional and behavioral factors related to weight gain after bariatric surgery
por: Palacio,Ana, et al.
Publicado: (2021) -
BARIATRIC SURGERIES AND CORRECTION OF METABOLIC DISORDERS IN PATIENTS WITH MORBID OBESITY
por: V. O. Khanov, et al.
Publicado: (2012) -
Assessment of education effects on patient involvement and bariatric treatment outcome: an observational study
por: Regina Sierżantowicz, et al.
Publicado: (2019)